Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P. Nov 14, 2025 04:25PM
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P. Aug 14, 2025 06:12PM
Form SC 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P. Nov 14, 2024 05:47PM
Form SC 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P. Feb 14, 2024 05:02PM
Form SC 13G Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P. Aug 25, 2023 05:02PM


Aug 14, 2023 07:02AM Taysha Gene Therapies (TSHA) Reports Initial Clinical Data from First Adult Rett Syndrome Patient Dosed in REVEAL Phase 1/2 Trial
Aug 14, 2023 07:02AM Taysha Gene Therapies Reports Initial Clinical Data from First Adult Rett Syndrome Patient Dosed in REVEAL Phase 1/2 Trial and Provides Corporate Update with Second Quarter 2023 Financial Results
Aug 14, 2023 07:00AM Taysha Gene Therapies (TSHA) Announces $150M Financing
Aug 14, 2023 07:00AM Taysha Gene Therapies Announces $150 Million Private Placement Financing